As additional support of the specificity of these surface markers for resistant nMRTF BCC, we examined their expression in Gorlin syndrome patient BCCs, which are caused by inherited loss of ptch1 and respond to vismodegib with almost no resistance30, as well as being consistently MRTF-inactive12. Here, PTCH1 is linked to skin basal cell carcinoma.